Company · CIK 0001428522 · SIC 2834 — Pharmaceutical Preparations
Radius Health, Inc. · RDUS
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 6, 2015 PForm 4 → | Mar 9, 4:35 pm EDT | Growth N Biotech V +110% Owner | 75,000 | $47.08 | $3,531,128 | 3,722,140 | +2.06% | plan? |
| Feb 25, 2015 PForm 4 → | Feb 27, 12:08 pm EST | Growth N Biotech V +110% Owner | 35,000 | $45.74 | $1,600,851 | 3,647,140 | +0.97% | plan? |
| Jan 16, 2015 JForm 4 → | Jan 16, 9:10 pm EST | F2 Bioscience IV L.P. +610% Owner | 2,666,834 | — | — | 0 | — | plan? amended |
| Jan 16, 2015 JForm 4 → | Jan 16, 9:09 pm EST | F2 Bioscience III, L.P. +410% Owner | 1,167,997 | — | — | 0 | — | plan? amended |
| Jan 8, 2015 JForm 4 → | Jan 12, 4:41 pm EST | F2 Bioscience III, L.P. +310% Owner | 389,331 | — | — | 1,167,997 | — | plan? amended |
| Jan 8, 2015 JForm 4 → | Jan 12, 4:40 pm EST | Morana Jovan-EmbiricosDirector, 10% Owner | 389,331 | — | — | 1,167,997 | — | plan? amended |
| Jul 10, 2014 JForm 4 → | Jan 15, 2015, 5:04 pm EST | F2 Bioscience IV L.P. +610% Owner | 587,500 | — | — | 0 | — | plan? late |
| Jul 10, 2014 JForm 4 → | Jan 15, 2015, 5:03 pm EST | Morana Jovan-EmbiricosDirector, 10% Owner | 587,500 | — | — | 0 | — | plan? late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| May 7, 2015 AForm 4 → | May 26, 7:15 pm EDT | Willard H DereDirector | 15,000 | — | — | 15,000 | — | late |
| May 7, 2015 AForm 4 → | May 26, 7:15 pm EDT | Owen HughesDirector | 15,000 | — | — | 15,000 | — | late |
| May 7, 2015 AForm 4 → | May 26, 7:14 pm EDT | Kurt GravesDirector | 15,000 | — | — | 15,000 | — | late |
| May 7, 2015 AForm 4 → | May 26, 7:14 pm EDT | Martin MuenchbachDirector | 15,000 | — | — | 15,000 | — | late |
| May 7, 2015 AForm 4 → | May 26, 7:14 pm EDT | Alan H AuerbachDirector | 15,000 | — | — | 15,000 | — | late |
| May 7, 2015 AForm 4 → | May 26, 7:14 pm EDT | Ansbert GadickeDirector, 10% Owner | 15,000 | — | — | 15,000 | — | late |
| Mar 18, 2015 AForm 4 → | Mar 19, 4:35 pm EDT | Dinesh PurandareSVP,Global Oncology/Commercial | 115,000 | — | — | 115,000 | — | |
| Mar 2, 2015 AForm 4 → | Mar 3, 4:15 pm EST | Anthony RosenbergDirector | 60,000 | — | — | 60,000 | — | |
| Jan 16, 2015 JForm 4/A → | Jan 20, 4:16 pm EST | F2 Bioscience IV L.P. +610% Owner | 371,328 | — | — | 0 | — | |
| Jan 16, 2015 JForm 4/A → | Jan 20, 4:16 pm EST | F2 Bioscience III, L.P. +410% Owner | 267,786 | — | — | 0 | — | |
| Jan 16, 2015 JForm 4 → | Jan 16, 9:10 pm EST | F2 Bioscience IV L.P. +610% Owner | 371,328 | — | — | 0 | — | amended |
| Jan 16, 2015 JForm 4 → | Jan 16, 9:09 pm EST | F2 Bioscience III, L.P. +410% Owner | 267,786 | — | — | 0 | — | amended |
| Jan 8, 2015 JForm 4/A → | Jan 20, 4:17 pm EST | F2 Bioscience III, L.P. +410% Owner | 89,261 | — | — | 267,786 | — | |
| Jan 8, 2015 JForm 4/A → | Jan 20, 4:17 pm EST | Morana Jovan-EmbiricosDirector, 10% Owner | 89,261 | — | — | 267,786 | — | |
| Jan 8, 2015 JForm 4 → | Jan 12, 4:41 pm EST | F2 Bioscience III, L.P. +310% Owner | 89,261 | — | — | 267,786 | — | amended |
| Jan 8, 2015 JForm 4 → | Jan 12, 4:40 pm EST | Morana Jovan-EmbiricosDirector, 10% Owner | 89,261 | — | — | 267,786 | — | amended |